A genetic etiology of pervasive developmental disorder guides treatment.
Solomon
Marjorie
M
Department of Psychiatry and Behavioral Sciences, MIND Institute, University of California, Davis, Sacramento, CA 95817, USA. marjorie.solomon@ucdmc.ucdavis.edu
Hessl
David
D
Chiu
Sufen
S
Hagerman
Randi
R
Hendren
Robert
R
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D001321:Autistic Disorder / Q000235:genetics / Q000628:therapy; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D015897:Comorbidity; D005260:Female; D005600:Fragile X Syndrome / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D006801:Humans; D009788:Occupational Therapy / Q000379:methods; D010641:Phenotype; D011613:Psychotherapy / Q000379:methods; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use
D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline